血清GSDMD在心力衰竭患者的诊断和进展价值:一项回顾性研究
Changmei Wei1, Nan Ding1, Xuexin Liu1
1Department of Medical Laboratory, Hebei General Hospital, Shijiazhuang, Hebei Province, People's Republic of China.
International journal of general medicine
|December 16, 2025
概括
血清加斯德明D (GSDMD) 显示为早期心力衰竭诊断和监测疾病进展的新生物标志物. 这项研究发现GSDMD水平与心力衰竭的严重程度相关,有助于早期检测.
科学领域:
- 心脏病学 心脏病学
- 生物标志物发现发现
- 临床诊断 临床诊断 临床诊断
背景情况:
- 心力衰竭 (HF) 诊断和进展监测仍然是关键的临床挑战.
- 对于早期检测和对高频率的准确评估,需要新的生物标志物.
- 加斯德明D (GSDMD) 涉及与心血管疾病相关的炎症过程.
研究的目的:
- 评估血清加斯德明D (GSDMD) 作为早期诊断心力衰竭的潜在新生物标志物.
- 评估GSDMD在监测心力衰竭疾病进展中的有用性.
- 将GSDMD的诊断性能与已知的生物标志物如NT-ProBNP和喷射分数 (EF) 进行比较.
主要方法:
- 对心力衰竭,其他心脏病和健康对照组的临床数据和实验室结果的回顾性分析.
- 在不同患者队伍中,血清GSDMD水平的比较.
- GSDMD与其他临床指标之间的相关性分析.
- 接收器操作特征 (ROC) 曲线分析以确定诊断准确性.
主要成果:
- 在这三个组中,血清GSDMD水平显著不同,并且随着心力衰竭的严重程度而增加.
- 血清GSDMD与各种临床指标有很强的相关性.
- GSDMD和NT-ProBNP被确定为独立的风险因素,而EF是心力衰竭的保护因素.
- 在诊断心力衰竭时,GSDMD的曲线下的面积 (AUC) 为0.819,与NT-ProBNP和EF的联合AUC为0.986.
结论:
- 血清GSDMD是一种新且敏感的生物标志物,在早期诊断心力衰竭方面具有显著的潜力.
- 在评估心力衰竭的进展方面,GSDMD可以很有价值.
- 与NT-ProBNP和EF的联合评估提高了心力衰竭的诊断准确度.
相关概念视频
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
443
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
443
01:30Cardiomyopathy II: Dilated Cardiomyopathy
436
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
436
01:30Heart Failure IV: Classification and Diagnostic Evaluation
293
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
293
01:30Acute Coronary Syndrome III: Diagnostic Studies
197
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
197
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
362
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
362
01:26Heart Failure III: Clinical Manifestations
440
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
440